首页> 外文期刊>Hippocampus >Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression.
【24h】

Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression.

机译:在抑郁症的遗传动物模型中,丙咪嗪治疗可增加海马突触和神经元的数量。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim was to investigate treatment effects of the antidepressant imipramine on the markers of neuronal plasticity. We investigated changes in neuron and synapse numbers in a rat strain that displays a genetic susceptibility to depressive behavior, the Flinders Sensitive and Resistant Lines (FSL/FRL). All rats were treated with imipramine (15 mg/kg) or saline (i.p) once daily for 25 days. The volume, neuron and synapse numbers in the hippocampus were estimated using design-based stereological methods. Under untreated conditions, the volume and the number of neurons and synapses were significantly smaller in the FSL saline group (untreated "depressed" rats) compared with the FRL saline group (normal rats), showing correlation to the observed decreased immobility in the forced swim test. Imipramine treatment significantly increased the number of neurons in the granule cell layer (GCL) and spine synapses in the CA1 in the FSL imipramine group (treated "depressed" rats) compared with the FSL saline group. The neuron numbers in the GCL and Hilus showed no differences in the FSL imipramine group compared to the FRL saline group. In conclusion, baseline levels of the volume and the number of neurons and spine synapses in hippocampus were significantly smaller in the untreated FSL rats. Our findings indicate that chronic imipramine treatment reverses the suppression of neurogenesis and synaptogenesis in the hippocampus of the "depressed" FSL rats, and this occurs in correlation with behavioral effects. Our results support the neuronal plasticity hypothesis that depressive disorders may be related to impairments of structural plasticity and neuronal viability in hippocampus, furthermore, antidepressant treatment counteracts the structural impairments.
机译:目的是研究抗抑郁药丙咪嗪对神经元可塑性标志物的治疗作用。我们调查了对抑郁行为表现出遗传易感性的弗林德斯敏感和抗性品系(FSL / FRL)的大鼠品系中神经元和突触数量的变化。每天用丙咪嗪(15 mg / kg)或生理盐水(i.p)治疗所有大鼠,持续25天。使用基于设计的立体学方法估计海马的体积,神经元和突触数量。在未治疗的条件下,与FRL生理盐水组(正常大鼠)相比,FSL生理盐水组(未经治疗的“抑郁”大鼠)的神经元和突触的数量,数量显着较小,这与强迫游泳中观察到的不运动减少有关测试。与FSL盐水组相比,FSL丙咪嗪组(治疗的“抑郁”大鼠)中,丙咪嗪治疗显着增加了CA1的颗粒细胞层(GCL)和脊柱突触中神经元的数量。与FRL盐水组相比,FSL丙咪嗪组的GCL和Hilus中的神经元数量没有差异。总之,在未经治疗的FSL大鼠中,海马体的体积,神经元和脊柱突触的基线水平显着降低。我们的发现表明,慢性丙咪嗪治疗可逆转“抑郁” FSL大鼠海马中神经发生和突触发生的抑制作用,这与行为效应相关。我们的结果支持神经元可塑性假说,即抑郁症可能与海马结构可塑性和神经元生存能力受损有关,此外,抗抑郁药可抵消结构性受损。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号